Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
2
×
boston blog main
life sciences
akcea therapeutics
alnylam pharmaceuticals
andrew fire
bioinnovation capital
biolabs
biotech
boston top stories
chemotherapy
clinical trials
craig mello
daraprim
drug pricing
drugs
epipen
epipens
exome
fda
gene therapy
generic drugs
hereditary transthyretin amyloidosis
inotersen
insulin
johannes fruehauf
john maraganore
labcentral
life science
martin shkreli
mylan
national blog main
national top stories
national xcon
new york blog main
new york top stories
nobel prize
novartis
oncology
onpattro
What
drug
history
2
×
afternoon
alnylam
alnylam’s
approved
biotech
driving
fda
gets
good
healthcare
improved
industry
innovation
innovations
investment
landmark
life
long
making
medical
medicine
ok
onpattro
outcomes
patisiran
pharmaceuticals
pricing
proud
public
rnai
sciences
specifically
wide
Language
unset
Current search:
history
×
boston
×
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug